New Antibody Formats
-10%
portes grátis
New Antibody Formats
Aranda Vega, Fernando; Galluzzi, Lorenzo; Berraondo, Pedro
Elsevier Science & Technology
06/2022
212
Dura
Inglês
9780323994026
15 a 20 dias
450
Descrição não disponível.
. Current innovative engineered antibodies Jose Yelamos 2. Opportunities and challenges of bi-specific antibodies Aina Segues, Shuyu Huang, Alice Sijts, Pedro Berraondo and Dietmar M. Zaiss 3. Applications of trimerbodies in cancer immunotherapy Marta Compte, Laura Sanz and Luis Alvarez-Vallina 4. Anticalin (R)-based therapeutics: Expanding new frontiers in drug development Aizea Morales-Kastresana, Martin Siegemund, Stefan Haak, Janet Peper-Gabriel, Vanessa Neiens and Christine Rothe 5. Overcoming the limitations of cytokines to improve cancer therapy Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Myriam Fernandez-Sendin, Angela Bella, Fernando Aranda, Ignacio Melero and Pedro Berraondo 6. Emerging applications of nanobodies in cancer therapy Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W.M. De Groof, Yannick De Vlaeminck, Ahmet Krasniqi, Kim De Veirman, Cleo Goyvaerts, Matthias D'Huyvetter, Sophie Hernot, Nick Devoogdt and Karine Breckpot
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
trimerbodies; bispecific antibodies; next-generation antibodies; cancer immunotherapy
. Current innovative engineered antibodies Jose Yelamos 2. Opportunities and challenges of bi-specific antibodies Aina Segues, Shuyu Huang, Alice Sijts, Pedro Berraondo and Dietmar M. Zaiss 3. Applications of trimerbodies in cancer immunotherapy Marta Compte, Laura Sanz and Luis Alvarez-Vallina 4. Anticalin (R)-based therapeutics: Expanding new frontiers in drug development Aizea Morales-Kastresana, Martin Siegemund, Stefan Haak, Janet Peper-Gabriel, Vanessa Neiens and Christine Rothe 5. Overcoming the limitations of cytokines to improve cancer therapy Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Myriam Fernandez-Sendin, Angela Bella, Fernando Aranda, Ignacio Melero and Pedro Berraondo 6. Emerging applications of nanobodies in cancer therapy Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W.M. De Groof, Yannick De Vlaeminck, Ahmet Krasniqi, Kim De Veirman, Cleo Goyvaerts, Matthias D'Huyvetter, Sophie Hernot, Nick Devoogdt and Karine Breckpot
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
